Investment
Features
FeesSafety
Academy
More
Pluang+

India's central bank holds interest rates at 5.25% despite inflation rising above target.

Market News
05 Aug 2026
CNBC
View Source
Neutral
India's central bank holds interest rates at 5.25% despite inflation rising above target.

India's central bank kept its benchmark interest rate steady at 5.25% for the fifth consecutive time, even as retail inflation rose to 4.38% in June, surpassing the RBI's 4% target. The RBI emphasized that core inflation, excluding volatile food and fuel prices, remains moderate but acknowledged inflation pressures mainly from rising fuel and food costs. The central bank is cautious about future rate changes, awaiting clearer inflation trends and considering economic growth factors. Inflation is expected to stay above 5% for several months, with some analysts predicting rate hikes later this year amid ongoing global energy price pressures and domestic economic challenges.

More News

Berkshire Hathaway poised for growth with $325B T-bills and strong insurance float amid rising rates

Berkshire Hathaway poised for growth with $325B T-bills and strong insurance float amid rising rates

Berkshire Hathaway is well-positioned to benefit from rising interest rates, holding $324.9 billion in Treasury bills that will reprice higher, alongside a $177.5 billion insurance float that funds its growth. Despite concerns about succession, Greg ...

Market News
Bullish
4 hours ago
XRP burn rate spikes 84% despite falling transactions, signaling a key shift in network activity.

XRP burn rate spikes 84% despite falling transactions, signaling a key shift in network activity.

The XRP Ledger's burn rate surged by 84.3%, with 771.7 XRP destroyed as transaction fees, even as transaction and payment volumes declined by around 6-7%. This unusual divergence suggests that the fee cost per transaction has increased significantly,...

Protocol Fundamentals
Neutral
4 hours ago
GH Research gets FDA clearance to start phase 3 trial for new depression treatment in 2026

GH Research gets FDA clearance to start phase 3 trial for new depression treatment in 2026

GH Research PLC has resolved the FDA clinical hold on its investigational new drug (IND) application for GH001, a treatment targeting resistant depression. This clearance allows the company to plan a pivotal phase 3 trial expected to begin in 2026. G...

Analyst Insights
Bullish
4 hours ago
Congressional Black Caucus backs AI regulation with nearly unanimous support for guardrails bill

Congressional Black Caucus backs AI regulation with nearly unanimous support for guardrails bill

The Congressional Black Caucus (CBC) is strongly supporting legislation to regulate artificial intelligence, with nearly all of its 62 members ready to vote in favor of AI guardrails to ensure transparency and safety. CBC leaders emphasize the need t...

Market News
Neutral
4 hours ago
US warns of rapid escalation in Middle East conflict as Iran keeps Strait of Hormuz closed

US warns of rapid escalation in Middle East conflict as Iran keeps Strait of Hormuz closed

The US State Department has urged Americans outside the Middle East to reconsider travel due to the risk of rapid escalation in the Iran conflict. Iran insists the Strait of Hormuz will remain closed until its demands are met, including ending the na...

Market News
Bearish
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App